Thraderm’s parent company, Therapon Skin Health, is—like many in the industry today—bringing bioscience and skin care together. The company’s portfolio comprises cleansers, moisturizers, treatments, acne care, anti-aging and more.
Theraderm products retail across the States and online through several marketplaces as well as the brand’s own e-commerce site.
A new twist
The formulation of Theraderm’s new daily Anti-Aging System products differs from the company’s popular Skin Renewal System in one key way. Rather than moisturizers, the new collection is blended with Eternox Peptide Crème, according the company’s press release. The crème is itself a mixture of three patented peptides.
"The active peptides in Eternox Peptide Crème have shown in clinical trials to provide excellent restoration to skin that has existing damage from aging," says James Beckman, the company’s founder and CEO.
"This system was specifically designed to prevent and repair aspects of skin damage that give an aging appearance," he adds.
Demand and supply
According to Theraderm, the existing Skin Renewal System was performing well, but consumers wanted a set of products that fit into their routine differently: "The Skin Renewal System is ideal for all ages and skin types and is formulated to improve overall skin health," says Beckman. "However, many users of Theraderm products have expressed an interest in a daily system that is specifically made to target deeper lines and wrinkles. That's what led to the creation of the Anti-Aging System."
Consumer feedback is perhaps more influential than ever and more immediate too. Thanks to social media, online comment options, and corporate intentions to stay ahead of the curve, the wants and opinions of product users get quite a bit of attention.
Theraderm’s company statement didn’t indicate just what channel the consumer feedback came over or how many requests for a daily-use collection they received. But it hardly matters. When a good idea and commercial potential intersect, it makes sense to move forward.